![]() To some extent, she has also plugged the brain drain of Indian scientists, making them collaborators in the fight against diabetes and cancer, and creating a space for research in India. Without a supportive academic ecosystem for biotechnology and in the absence of sound policymaking, Mazumdar-Shaw has tirelessly sought out global alliances and resources in her quest for ideas and molecules. And the accidental entrepreneur, Mazumdar-Shaw, is today a tough negotiator and a habitual dealmaker, casually breaking several myths about Indian women in business. Thirty-seven years on, Biocon is India's largest research-driven biotech enterprise. Armed with just a degree in beer making, this move to industrial enzymes and commodity small molecules was as audacious as it was far-sighted. ![]() ![]() Jeremy Levin, former CEO of Teva and current chairman and CEO of Ovid TherapeuticsĪt the age of twenty-five, Kiran Mazumdar-Shaw partnered with an Irish entrepreneur, Leslie Auchincloss, to start Biocon India in a garage in Bengaluru. ![]() In Kiran's case, she likes to make everyone around her feel successful.' You have to live in an environment where, to make a deal successful, you have to make everyone successful or everyone own the failure you have to know what the risks are and what the success will be. ![]() Most people in larger companies don't like making deals because, if they go wrong, they lose their career if they go right, their superior takes the credit. ![]()
0 Comments
Leave a Reply. |